DecomBio, incorporated in California, consists of a multidisciplinary team of researchers and physicians at UCSF and UC Berkeley. They specialize in assembling, packaging and distributing colloidal gold diagnostic instruments in North America. Their product received acknowledgment from the U.S. FDA, with permission to distribute.
[mepr-show rules=”18700″ unauth=”message”]
DecomBio’s Noval Coronavirus (SARS- COV-2) IgM/IgG Combo Rapid Test uses Whole blood, serum, or plasma to direct the presence of the virus. The test can be used at home or administered by a healthcare professional and results are available in 20 minutes. The FDA has approved the test and is in the final stages of EUA approval